Concepedia

Shangzhi Shu

SS

5

Publications

74

Citations

5

H-Index

2019

Active since

Affiliations

Jilin University(Current)

First Hospital of Jilin University

Second Affiliated Hospital of Jilin University

Yanbian University Hospital

Yanbian University

Shangzhi Shu is an author at Jilin University specializing in signal transduction, cardiac reprogramming, and cell signaling.

ORCID

Top concepts

Publications per year

2019–2024

5

Publications

5

Novel Role for Pleckstrin Homology‐Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy

Jia Liu, Xiaoxiong Liu, Xuejun Hui et al. · Journal of the American Heart Association · 2019 · 19 citations · Full text

FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway

Xuejun Hui, Fengjiao Hu, Jia Liu et al. · Journal of Molecular and Cellular Cardiology · 2020 · 17 citations

, , +12

CD8+ T-cell deficiency protects mice from abdominal aortic aneurysm formation in response to calcium chloride2

Lin Zhuo, Mantong Zhao, Xian Zhang et al. · Journal of Hypertension · 2024 · 13 citations · Full text

Histone deacetylase 6 controls cardiac fibrosis and remodelling through the modulation of <scp>TGF</scp>‐β1/Smad2/3 signalling in post‐infarction mice

Junqiao Fang, Shangzhi Shu, Hui Dong et al. · Journal of Cellular and Molecular Medicine · 2024 · 13 citations · Full text

Dipeptidyl peptidase‐4 disturbs adipocyte differentiation via the negative regulation of the glucagon‐like peptide‐1/adiponectin‐cathepsin K axis in mice under chronic stress conditions

Meiping Zhang, Xueling Yue, Shengnan Xu et al. · The FASEB Journal · 2024 · 12 citations · Full text

Rows per page

1–5 of 5